AU-011 (Belzupacap Sarotalocan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AU-011 (Belzupacap Sarotalocan), covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma [Phase 3]